Greenbaum Cancer Center, University of Maryland

Site:	Greenbaum Cancer Center, University of Maryland
Address:
City:	Baltimore
State:	MD
Zip:	21201
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor	Completed	Closed	KW2450	NCT00921336
1	Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors	Completed	Closed	Navitoclax + Sorafenib	NCT02143401